Get Real Time Here
| Open1.090 | Close1.040 |
| Vol / Avg.48.198K / 140.386K | Mkt Cap31.917M |
| Day Range1.000 - 1.090 | 52 Wk Range0.901 - 3.950 |
IN8bio Stock (NASDAQ:INAB), Quotes and News Summary
IN8bio Stock (NASDAQ: INAB) stock price, news, charts, stock research, profile.
| Open1.090 | Close1.040 |
| Vol / Avg.48.198K / 140.386K | Mkt Cap31.917M |
| Day Range1.000 - 1.090 | 52 Wk Range0.901 - 3.950 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.270 | -0.270 | 0.0000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-11 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | BuyBuy | Maintains | - | 14.00 |
| 2023-06-05 | EF Hutton | Tony Butler | Reiterates | BuyBuy | Maintains | - | 8.00 |
| 2023-05-16 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | BuyBuy | Maintains | - | 14.00 |
| 2023-04-26 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | Buy | Maintains | - | 14.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| INAB | IN8bio | -9.01% | 31.9M |
| FBIO | Fortress Biotech | 6.67% | 42.6M |
| COEP | Coeptis Therapeutics | 10.28% | 34.4M |
| ALGS | Aligos Therapeutics | 2.33% | 32.5M |
| BOLT | Bolt Biotherapeutics | -3.85% | 38M |
How do I buy IN8bio (INAB) stock?
You can purchase shares of IN8bio (NASDAQ: INAB) through any online brokerage.
Who are IN8bio's (INAB) competitors?
Other companies in IN8bio’s space includes: Fortress Biotech (NASDAQ:FBIO), Coeptis Therapeutics (NASDAQ:COEP), Aligos Therapeutics (NASDAQ:ALGS), Bolt Biotherapeutics (NASDAQ:BOLT) and NuCana (NASDAQ:NCNA).
What is the target price for IN8bio (INAB) stock?
The latest price target for IN8bio (NASDAQ: INAB) was reported by HC Wainwright & Co. on Friday, August 11, 2023. The analyst firm set a price target for 14.00 expecting INAB to rise to within 12 months (a possible 1286.14% upside). 10 analyst firms have reported ratings in the last year.
Current Stock Price for IN8bio (INAB)?
The stock price for IN8bio (NASDAQ: INAB) is $1.01 last updated September 29, 2023 at 11:33 PM UTC.
Does IN8bio (INAB) pay a dividend?
There is no dividend information for IN8bio.
When is IN8bio (NASDAQ:INAB) reporting earnings?
IN8bio’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is IN8bio (INAB) going to split?
There is no upcoming split for IN8bio.
What sector and industry does IN8bio (INAB) operate in?
IN8bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
IN8bio Stock (NASDAQ:INAB), Quotes and News Summary
IN8bio Stock (NASDAQ: INAB) stock price, news, charts, stock research, profile.
| Open1.090 | Close1.040 |
| Vol / Avg.48.198K / 140.386K | Mkt Cap31.917M |
| Day Range1.000 - 1.090 | 52 Wk Range0.901 - 3.950 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.270 | -0.270 | 0.0000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-11 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | BuyBuy | Maintains | - | 14.00 |
| 2023-06-05 | EF Hutton | Tony Butler | Reiterates | BuyBuy | Maintains | - | 8.00 |
| 2023-05-16 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | BuyBuy | Maintains | - | 14.00 |
| 2023-04-26 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | Buy | Maintains | - | 14.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| INAB | IN8bio | -9.01% | 31.9M |
| FBIO | Fortress Biotech | 6.67% | 42.6M |
| COEP | Coeptis Therapeutics | 10.28% | 34.4M |
| ALGS | Aligos Therapeutics | 2.33% | 32.5M |
| BOLT | Bolt Biotherapeutics | -3.85% | 38M |
How do I buy IN8bio (INAB) stock?
You can purchase shares of IN8bio (NASDAQ: INAB) through any online brokerage.
Who are IN8bio's (INAB) competitors?
Other companies in IN8bio’s space includes: Fortress Biotech (NASDAQ:FBIO), Coeptis Therapeutics (NASDAQ:COEP), Aligos Therapeutics (NASDAQ:ALGS), Bolt Biotherapeutics (NASDAQ:BOLT) and NuCana (NASDAQ:NCNA).
What is the target price for IN8bio (INAB) stock?
The latest price target for IN8bio (NASDAQ: INAB) was reported by HC Wainwright & Co. on Friday, August 11, 2023. The analyst firm set a price target for 14.00 expecting INAB to rise to within 12 months (a possible 1286.14% upside). 10 analyst firms have reported ratings in the last year.
Current Stock Price for IN8bio (INAB)?
The stock price for IN8bio (NASDAQ: INAB) is $1.01 last updated September 29, 2023 at 11:33 PM UTC.
Does IN8bio (INAB) pay a dividend?
There is no dividend information for IN8bio.
When is IN8bio (NASDAQ:INAB) reporting earnings?
IN8bio’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is IN8bio (INAB) going to split?
There is no upcoming split for IN8bio.
What sector and industry does IN8bio (INAB) operate in?
IN8bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
IN8bio Stock (NASDAQ:INAB), Quotes and News Summary
IN8bio Stock (NASDAQ: INAB) stock price, news, charts, stock research, profile.
| Open1.090 | Close1.040 |
| Vol / Avg.48.198K / 140.386K | Mkt Cap31.917M |
| Day Range1.000 - 1.090 | 52 Wk Range0.901 - 3.950 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.270 | -0.270 | 0.0000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-11 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | BuyBuy | Maintains | - | 14.00 |
| 2023-06-05 | EF Hutton | Tony Butler | Reiterates | BuyBuy | Maintains | - | 8.00 |
| 2023-05-16 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | BuyBuy | Maintains | - | 14.00 |
| 2023-04-26 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | Buy | Maintains | - | 14.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| INAB | IN8bio | -9.01% | 31.9M |
| FBIO | Fortress Biotech | 6.67% | 42.6M |
| COEP | Coeptis Therapeutics | 10.28% | 34.4M |
| ALGS | Aligos Therapeutics | 2.33% | 32.5M |
| BOLT | Bolt Biotherapeutics | -3.85% | 38M |
How do I buy IN8bio (INAB) stock?
You can purchase shares of IN8bio (NASDAQ: INAB) through any online brokerage.
Who are IN8bio's (INAB) competitors?
Other companies in IN8bio’s space includes: Fortress Biotech (NASDAQ:FBIO), Coeptis Therapeutics (NASDAQ:COEP), Aligos Therapeutics (NASDAQ:ALGS), Bolt Biotherapeutics (NASDAQ:BOLT) and NuCana (NASDAQ:NCNA).
What is the target price for IN8bio (INAB) stock?
The latest price target for IN8bio (NASDAQ: INAB) was reported by HC Wainwright & Co. on Friday, August 11, 2023. The analyst firm set a price target for 14.00 expecting INAB to rise to within 12 months (a possible 1286.14% upside). 10 analyst firms have reported ratings in the last year.
Current Stock Price for IN8bio (INAB)?
The stock price for IN8bio (NASDAQ: INAB) is $1.01 last updated September 29, 2023 at 11:33 PM UTC.
Does IN8bio (INAB) pay a dividend?
There is no dividend information for IN8bio.
When is IN8bio (NASDAQ:INAB) reporting earnings?
IN8bio’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is IN8bio (INAB) going to split?
There is no upcoming split for IN8bio.
What sector and industry does IN8bio (INAB) operate in?
IN8bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
IN8bio Stock (NASDAQ:INAB), Quotes and News Summary
IN8bio Stock (NASDAQ: INAB) stock price, news, charts, stock research, profile.
| Open1.090 | Close1.040 |
| Vol / Avg.48.198K / 140.386K | Mkt Cap31.917M |
| Day Range1.000 - 1.090 | 52 Wk Range0.901 - 3.950 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.270 | -0.270 | 0.0000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-11 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | BuyBuy | Maintains | - | 14.00 |
| 2023-06-05 | EF Hutton | Tony Butler | Reiterates | BuyBuy | Maintains | - | 8.00 |
| 2023-05-16 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | BuyBuy | Maintains | - | 14.00 |
| 2023-04-26 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | Buy | Maintains | - | 14.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| INAB | IN8bio | -9.01% | 31.9M |
| FBIO | Fortress Biotech | 6.67% | 42.6M |
| COEP | Coeptis Therapeutics | 10.28% | 34.4M |
| ALGS | Aligos Therapeutics | 2.33% | 32.5M |
| BOLT | Bolt Biotherapeutics | -3.85% | 38M |
How do I buy IN8bio (INAB) stock?
You can purchase shares of IN8bio (NASDAQ: INAB) through any online brokerage.
Who are IN8bio's (INAB) competitors?
Other companies in IN8bio’s space includes: Fortress Biotech (NASDAQ:FBIO), Coeptis Therapeutics (NASDAQ:COEP), Aligos Therapeutics (NASDAQ:ALGS), Bolt Biotherapeutics (NASDAQ:BOLT) and NuCana (NASDAQ:NCNA).
What is the target price for IN8bio (INAB) stock?
The latest price target for IN8bio (NASDAQ: INAB) was reported by HC Wainwright & Co. on Friday, August 11, 2023. The analyst firm set a price target for 14.00 expecting INAB to rise to within 12 months (a possible 1286.14% upside). 10 analyst firms have reported ratings in the last year.
Current Stock Price for IN8bio (INAB)?
The stock price for IN8bio (NASDAQ: INAB) is $1.01 last updated September 29, 2023 at 11:33 PM UTC.
Does IN8bio (INAB) pay a dividend?
There is no dividend information for IN8bio.
When is IN8bio (NASDAQ:INAB) reporting earnings?
IN8bio’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is IN8bio (INAB) going to split?
There is no upcoming split for IN8bio.
What sector and industry does IN8bio (INAB) operate in?
IN8bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
IN8bio Stock (NASDAQ:INAB), Quotes and News Summary
IN8bio Stock (NASDAQ: INAB) stock price, news, charts, stock research, profile.
| Open1.090 | Close1.040 |
| Vol / Avg.48.198K / 140.386K | Mkt Cap31.917M |
| Day Range1.000 - 1.090 | 52 Wk Range0.901 - 3.950 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.270 | -0.270 | 0.0000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-11 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | BuyBuy | Maintains | - | 14.00 |
| 2023-06-05 | EF Hutton | Tony Butler | Reiterates | BuyBuy | Maintains | - | 8.00 |
| 2023-05-16 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | BuyBuy | Maintains | - | 14.00 |
| 2023-04-26 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | Buy | Maintains | - | 14.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| INAB | IN8bio | -9.01% | 31.9M |
| FBIO | Fortress Biotech | 6.67% | 42.6M |
| COEP | Coeptis Therapeutics | 10.28% | 34.4M |
| ALGS | Aligos Therapeutics | 2.33% | 32.5M |
| BOLT | Bolt Biotherapeutics | -3.85% | 38M |
How do I buy IN8bio (INAB) stock?
You can purchase shares of IN8bio (NASDAQ: INAB) through any online brokerage.
Who are IN8bio's (INAB) competitors?
Other companies in IN8bio’s space includes: Fortress Biotech (NASDAQ:FBIO), Coeptis Therapeutics (NASDAQ:COEP), Aligos Therapeutics (NASDAQ:ALGS), Bolt Biotherapeutics (NASDAQ:BOLT) and NuCana (NASDAQ:NCNA).
What is the target price for IN8bio (INAB) stock?
The latest price target for IN8bio (NASDAQ: INAB) was reported by HC Wainwright & Co. on Friday, August 11, 2023. The analyst firm set a price target for 14.00 expecting INAB to rise to within 12 months (a possible 1286.14% upside). 10 analyst firms have reported ratings in the last year.
Current Stock Price for IN8bio (INAB)?
The stock price for IN8bio (NASDAQ: INAB) is $1.01 last updated September 29, 2023 at 11:33 PM UTC.
Does IN8bio (INAB) pay a dividend?
There is no dividend information for IN8bio.
When is IN8bio (NASDAQ:INAB) reporting earnings?
IN8bio’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is IN8bio (INAB) going to split?
There is no upcoming split for IN8bio.
What sector and industry does IN8bio (INAB) operate in?
IN8bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
IN8bio Stock (NASDAQ:INAB), Quotes and News Summary
IN8bio Stock (NASDAQ: INAB) stock price, news, charts, stock research, profile.
| Open1.090 | Close1.040 |
| Vol / Avg.48.198K / 140.386K | Mkt Cap31.917M |
| Day Range1.000 - 1.090 | 52 Wk Range0.901 - 3.950 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.270 | -0.270 | 0.0000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-11 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | BuyBuy | Maintains | - | 14.00 |
| 2023-06-05 | EF Hutton | Tony Butler | Reiterates | BuyBuy | Maintains | - | 8.00 |
| 2023-05-16 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | BuyBuy | Maintains | - | 14.00 |
| 2023-04-26 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | Buy | Maintains | - | 14.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| INAB | IN8bio | -9.01% | 31.9M |
| FBIO | Fortress Biotech | 6.67% | 42.6M |
| COEP | Coeptis Therapeutics | 10.28% | 34.4M |
| ALGS | Aligos Therapeutics | 2.33% | 32.5M |
| BOLT | Bolt Biotherapeutics | -3.85% | 38M |
How do I buy IN8bio (INAB) stock?
You can purchase shares of IN8bio (NASDAQ: INAB) through any online brokerage.
Who are IN8bio's (INAB) competitors?
Other companies in IN8bio’s space includes: Fortress Biotech (NASDAQ:FBIO), Coeptis Therapeutics (NASDAQ:COEP), Aligos Therapeutics (NASDAQ:ALGS), Bolt Biotherapeutics (NASDAQ:BOLT) and NuCana (NASDAQ:NCNA).
What is the target price for IN8bio (INAB) stock?
The latest price target for IN8bio (NASDAQ: INAB) was reported by HC Wainwright & Co. on Friday, August 11, 2023. The analyst firm set a price target for 14.00 expecting INAB to rise to within 12 months (a possible 1286.14% upside). 10 analyst firms have reported ratings in the last year.
Current Stock Price for IN8bio (INAB)?
The stock price for IN8bio (NASDAQ: INAB) is $1.01 last updated September 29, 2023 at 11:33 PM UTC.
Does IN8bio (INAB) pay a dividend?
There is no dividend information for IN8bio.
When is IN8bio (NASDAQ:INAB) reporting earnings?
IN8bio’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is IN8bio (INAB) going to split?
There is no upcoming split for IN8bio.
What sector and industry does IN8bio (INAB) operate in?
IN8bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
IN8bio Stock (NASDAQ:INAB), Quotes and News Summary
IN8bio Stock (NASDAQ: INAB) stock price, news, charts, stock research, profile.
| Open1.090 | Close1.040 |
| Vol / Avg.48.198K / 140.386K | Mkt Cap31.917M |
| Day Range1.000 - 1.090 | 52 Wk Range0.901 - 3.950 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.270 | -0.270 | 0.0000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-11 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | BuyBuy | Maintains | - | 14.00 |
| 2023-06-05 | EF Hutton | Tony Butler | Reiterates | BuyBuy | Maintains | - | 8.00 |
| 2023-05-16 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | BuyBuy | Maintains | - | 14.00 |
| 2023-04-26 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | Buy | Maintains | - | 14.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| INAB | IN8bio | -9.01% | 31.9M |
| FBIO | Fortress Biotech | 6.67% | 42.6M |
| COEP | Coeptis Therapeutics | 10.28% | 34.4M |
| ALGS | Aligos Therapeutics | 2.33% | 32.5M |
| BOLT | Bolt Biotherapeutics | -3.85% | 38M |
How do I buy IN8bio (INAB) stock?
You can purchase shares of IN8bio (NASDAQ: INAB) through any online brokerage.
Who are IN8bio's (INAB) competitors?
Other companies in IN8bio’s space includes: Fortress Biotech (NASDAQ:FBIO), Coeptis Therapeutics (NASDAQ:COEP), Aligos Therapeutics (NASDAQ:ALGS), Bolt Biotherapeutics (NASDAQ:BOLT) and NuCana (NASDAQ:NCNA).
What is the target price for IN8bio (INAB) stock?
The latest price target for IN8bio (NASDAQ: INAB) was reported by HC Wainwright & Co. on Friday, August 11, 2023. The analyst firm set a price target for 14.00 expecting INAB to rise to within 12 months (a possible 1286.14% upside). 10 analyst firms have reported ratings in the last year.
Current Stock Price for IN8bio (INAB)?
The stock price for IN8bio (NASDAQ: INAB) is $1.01 last updated September 29, 2023 at 11:33 PM UTC.
Does IN8bio (INAB) pay a dividend?
There is no dividend information for IN8bio.
When is IN8bio (NASDAQ:INAB) reporting earnings?
IN8bio’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is IN8bio (INAB) going to split?
There is no upcoming split for IN8bio.
What sector and industry does IN8bio (INAB) operate in?
IN8bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
IN8bio Stock (NASDAQ:INAB), Quotes and News Summary
IN8bio Stock (NASDAQ: INAB) stock price, news, charts, stock research, profile.
| Open1.090 | Close1.040 |
| Vol / Avg.48.198K / 140.386K | Mkt Cap31.917M |
| Day Range1.000 - 1.090 | 52 Wk Range0.901 - 3.950 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.270 | -0.270 | 0.0000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-11 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | BuyBuy | Maintains | - | 14.00 |
| 2023-06-05 | EF Hutton | Tony Butler | Reiterates | BuyBuy | Maintains | - | 8.00 |
| 2023-05-16 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | BuyBuy | Maintains | - | 14.00 |
| 2023-04-26 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | Buy | Maintains | - | 14.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| INAB | IN8bio | -9.01% | 31.9M |
| FBIO | Fortress Biotech | 6.67% | 42.6M |
| COEP | Coeptis Therapeutics | 10.28% | 34.4M |
| ALGS | Aligos Therapeutics | 2.33% | 32.5M |
| BOLT | Bolt Biotherapeutics | -3.85% | 38M |
How do I buy IN8bio (INAB) stock?
You can purchase shares of IN8bio (NASDAQ: INAB) through any online brokerage.
Who are IN8bio's (INAB) competitors?
Other companies in IN8bio’s space includes: Fortress Biotech (NASDAQ:FBIO), Coeptis Therapeutics (NASDAQ:COEP), Aligos Therapeutics (NASDAQ:ALGS), Bolt Biotherapeutics (NASDAQ:BOLT) and NuCana (NASDAQ:NCNA).
What is the target price for IN8bio (INAB) stock?
The latest price target for IN8bio (NASDAQ: INAB) was reported by HC Wainwright & Co. on Friday, August 11, 2023. The analyst firm set a price target for 14.00 expecting INAB to rise to within 12 months (a possible 1286.14% upside). 10 analyst firms have reported ratings in the last year.
Current Stock Price for IN8bio (INAB)?
The stock price for IN8bio (NASDAQ: INAB) is $1.01 last updated September 29, 2023 at 11:33 PM UTC.
Does IN8bio (INAB) pay a dividend?
There is no dividend information for IN8bio.
When is IN8bio (NASDAQ:INAB) reporting earnings?
IN8bio’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is IN8bio (INAB) going to split?
There is no upcoming split for IN8bio.
What sector and industry does IN8bio (INAB) operate in?
IN8bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
IN8bio Stock (NASDAQ:INAB), Quotes and News Summary
IN8bio Stock (NASDAQ: INAB) stock price, news, charts, stock research, profile.
| Open1.090 | Close1.040 |
| Vol / Avg.48.198K / 140.386K | Mkt Cap31.917M |
| Day Range1.000 - 1.090 | 52 Wk Range0.901 - 3.950 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.270 | -0.270 | 0.0000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-11 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | BuyBuy | Maintains | - | 14.00 |
| 2023-06-05 | EF Hutton | Tony Butler | Reiterates | BuyBuy | Maintains | - | 8.00 |
| 2023-05-16 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | BuyBuy | Maintains | - | 14.00 |
| 2023-04-26 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | Buy | Maintains | - | 14.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| INAB | IN8bio | -9.01% | 31.9M |
| FBIO | Fortress Biotech | 6.67% | 42.6M |
| COEP | Coeptis Therapeutics | 10.28% | 34.4M |
| ALGS | Aligos Therapeutics | 2.33% | 32.5M |
| BOLT | Bolt Biotherapeutics | -3.85% | 38M |
How do I buy IN8bio (INAB) stock?
You can purchase shares of IN8bio (NASDAQ: INAB) through any online brokerage.
Who are IN8bio's (INAB) competitors?
Other companies in IN8bio’s space includes: Fortress Biotech (NASDAQ:FBIO), Coeptis Therapeutics (NASDAQ:COEP), Aligos Therapeutics (NASDAQ:ALGS), Bolt Biotherapeutics (NASDAQ:BOLT) and NuCana (NASDAQ:NCNA).
What is the target price for IN8bio (INAB) stock?
The latest price target for IN8bio (NASDAQ: INAB) was reported by HC Wainwright & Co. on Friday, August 11, 2023. The analyst firm set a price target for 14.00 expecting INAB to rise to within 12 months (a possible 1286.14% upside). 10 analyst firms have reported ratings in the last year.
Current Stock Price for IN8bio (INAB)?
The stock price for IN8bio (NASDAQ: INAB) is $1.01 last updated September 29, 2023 at 11:33 PM UTC.
Does IN8bio (INAB) pay a dividend?
There is no dividend information for IN8bio.
When is IN8bio (NASDAQ:INAB) reporting earnings?
IN8bio’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is IN8bio (INAB) going to split?
There is no upcoming split for IN8bio.
What sector and industry does IN8bio (INAB) operate in?
IN8bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.